Pharmaceutical Executive
April 15, 2009
0
0
After last week’s flurry of FDA warning letters directed at companies marketing through search ads, industry is left wondering what can be done be done to target patients online?
April 15, 2009
News Analysis
0
0
Rather than ignore its aging mini-stroke medication Aggrenox, BI has shifted marketing to education by launching an unbranded site dedicated to informing sufferers about transient ischemic attacks, better known as TIA.
April 15, 2009
0
0
How to draft enforceable post-employment restriction agreements that will protect trade secrets and customer goodwill.
April 15, 2009
News Analysis
0
0
In an effort to realign its sales division to reflect the current pharma environment-smaller, faster, better-Johnson & Johnson is trimming its sales force.